TANAKA EIJI
School of Medicine Department for the Promotion of Regional Medicine
Professor
Researcher Information
Research Keyword
- viral hepatitis, autoimmune liver diseases, metabolic liver diseases
Career
Educational Background
Research activity information
Paper
- Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma
Sato K, Uehara T, Iwaya M, Nakajima T, Miyagawa Y, Ota H, Tanaka E
Ann Diagn Pathol, 48, 151587, Oct. 2020
Last - Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
Matsumoto A, Nishiguchi S, Enomoto H, Tanaka Y, Shinkai N, Okuse C, Kang JH, Matsui T, Miyase S, Yatsuhashi H, Nagaoka S, Kanda T, Enomoto M, Yamada R, Hiramatsu N, Saito S, Takaguchi K, Ito K, Masaki T, Morihara D, Tsuge M, Chayama K, Ikeda F, Kagawa T, Kondo Y, Murata K, Tanaka E
J Gastroenterol, 55(10), 977-989, Oct. 2020
Last - Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection
Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E
JGH Open, 4(4), 574-581, Aug. 2020
Last - Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus
Fujimori N, Tanaka N, Kimura T, Sano K, Horiuchi A, Kato N, Takahashi Y, Kuribayashi N, Sugiura A, Yamazaki T, Joshita S, Umemura T, Matsumoto A, Tanaka E
Clin J Gastroenterol, 13(1), 83-89, Feb. 2020
Last - Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine
Sato K, Suga T, Hirayama A, Daikuhara S, Uehara T, Tanaka E
Clin J Gastroenterol, 13(1), 1-5, Feb. 2020
Last - Virological Factors Associated With the Occurrence of Hepatitis B Virus (HBV) Reactivation in Patients With Resolved HBV Infection Analyzed Through Ultradeep Sequencing
Sakamoto K, Umemura T, Ito K, Okumura A, Joshita S, Ota M, Sugiyama M, Mizokami M, Yoneda M, Tanaka E
J Infect Dis, 221(3), Jan. 2020
Last - 【内科医が知っておくべき肝移植の実際】脳死肝移植レシピエントの適応と選択 令和になっての改訂
田中榮司
消化器・肝臓内科, 7(3), 231-237, 2020
Lead - 既存抗ウイルス療法の限界
田中榮司
臨床消化器内科, 35(2), 125-126, 2020
Lead - 胆嚢癌との鑑別が困難な画像所見を呈した胆嚢線維性ポリープの1例
芦原典宏, 渡邉貴之, 倉石康弘, 小澤真希子, 中村晃, 金井圭太, 大月聡明, 浜野英明, 田中榮司
胆道, 33(5), 854-861, Dec. 2019 - Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis
Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T
J Gastroenterol Hepatol, Nov. 2019 - KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
Umemura T, Joshita S, Saito H, Yoshizawa K, Norman GL, Tanaka E, Ota M
JHEP Rep, 1(5), 353-360, Nov. 2019 - Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma
Kuraishi Y, Uehara T, Kobayashi Y, Nakajima T, Watanabe T, Shimizu A, Ota H, Tanaka E:
Pathol Res Pract, 215(11), 152623, Nov. 2019 - Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
Joshita S, Umemura T, Yamashita Y, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E
Hepatol Res, 49(10), 1236-1243, Oct. 2019 - 嚢胞周囲に限局した自己免疫性膵炎の1例
小澤真希子, 渡邉貴之, 芦原典宏, 倉石康弘, 中村晃, 金井圭太, 松本有機, 小林実喜子, 田中榮司
膵臓, 34(5), 239-246, Oct. 2019 - Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society
Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, Uemoto S, Ohdan H
Hepatol Res, 49(9), 964-980, Sep. 2019 - Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection
Kobayashi S, Joshita S, Yamamoto C, Yanagisawa T, Miyazawa T, Miyazawa M, Kubota D, Sato J, Umemura T, Tanaka E
Medicine (Baltimore), 98(30), e16619, Jul. 2019 - What will happen in patients with advanced nonalcoholic fatty liver
Kimura T, Tanaka N, Tanaka E
Hepatobiliary Surg Nutr, 8(3), 283-285, Jun. 2019 - Response to the letter by Matsushita et al. regarding our manuscript "Resection Depth and Layer of Cold Snare Polypectomy versus Endoscopic Mucosal Resection"
Suga T, Ito A, Ota H, Tateiwa N, Matsumoto A, Tanaka E
J Gastroenterol, 54(5), 473, May 2019 - 【肝臓病学の未来-ウイルス性肝炎から脂肪肝と肝がんの時代へ】NAFLD/NASH 期待される新薬
田中直樹, 木村岳史, 藤森尚之, 田中榮司
内科, 123(5), 1155-1158, May 2019 - Red plasma and ascites under ultraviolet A
Wakabayashi SI, Kimura T, Tanaka N, Komatsu M, Tanaka E
Lancet Gastroenterol Hepatol, 4(4), 324, Apr. 2019 - A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax
Kako S, Joshita S, Matsuo A, Kawaguchi K, Umemura T, Tanaka E
Case Rep Oncol Med, 8357893, Mar. 2019 - Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
Umemura T, Joshita S, Shibata S, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E
Medicine (Baltimore), 98(6), e14475, Feb. 2019 - 【消化器癌の危険因子・予防対策】 肝臓癌のリスクファクターと予防対策 肝炎ウイルス以外
田中直樹, 木村岳史, 藤森尚之, 田中榮司
消化器・肝臓内科, 5(2), 215-221, Feb. 2019 - ウイルス肝炎と歩んだ40年
田中榮司
信州医学雑誌, 67(1), 27-30, Feb. 2019 - Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E
World J Gastroenterol, 25(2), 163-177, Jan. 2019 - Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients
Komatsu M, Tanaka N, Kimura T, Fujimori N, Sano K, Horiuchi A, Sugiura A, Yamazaki T, Shibata S, Joshita S, Umemura T, Matsumoto A, Tanaka E
Hepatol Res, 48(13), 1092-1098, Dec. 2018 - Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals
Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E
J Viral Hepat, 25(12), 1462-1471, Dec. 2018 - Resection depth and layer of cold snare polypectomy versus endoscopic mucosal resection
Ito A, Suga T, Ota H, Tateiwa N, Matsumoto A, Tanaka E
J Gastroenterol, 53(11), 1171-1178, Nov. 2018 - Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C
Umemura T, Yamazaki T, Joshita S, Sugiura A, Fujimori N, Matsumoto A, Ota M, Tanaka E
CYTOKINE, 111, 357-363, Oct. 2018 - Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma
Wakabayashi SI, Kimura T, Tanaka N, Joshita S, Kawata K, Umemura T, Hiroshima Y, Mori H, Kobayashi H, Wada S, Tanaka E
Clin J Gastroenterol, 11(4), 302-308, Aug. 2018 - A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
Yamazaki T, Umemura T, Joshita S, Yoshizawa K, Tanaka E, Ota M
Sci Rep, 8(1), 11924, Aug. 2018 - Hepatic Angiosarcoma with Kasabach-Merritt Phenomenon: A Case Report and Review of the Literature
Fujii F, Kimura T, Tanaka N, Kubota D, Sugiura A, Umemura T, Wada S, Tanaka E
Ann Hepatol, 17(4), 655-660, Jul. 2018 - Accuracy of Endoscopic Diagnosis for Mild Atrophic Gastritis Infected with Helicobacter pylori
Okamura T, Iwaya Y, Kitahara K, Suga T, Tanaka E
Clin Endosc, 51(4), 362-367, Jul. 2018 - Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E
Sci Rep, 8(1), 8159, May 2018 - Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma
Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K
Sci Rep, 8(1), 7958, May 2018 - A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature
Yamazaki T, Joshita S, Kasuga E, Horiuchi K, Sugiura A, Fujimori N, Komatsu M, Umemura T, Matsumoto A, Tanaka E
J Infect Chemother, 24(5), 393-397, May 2018 - Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E
World J Gastroenterol, 24(13), 1440-1450, Apr. 2018 - KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients
Saito H, Umemura T, Joshita S, Yamazaki T, Fujimori N, Kimura T, Komatsu M, Matsumoto A, Tanaka E, Ota M
Oncotarget, 9(28), 19650-19661, Apr. 2018 - Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E
World J Gastroenterol, 24(11), 1239-1249, Mar. 2018 - Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection
Joshita S, Ichikawa Y, Umemura T, Usami Y, Sugiura A, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Igarashi K, Ota M, Tanaka E
Hepatol Res, 48(4), 275-285, Mar. 2018 - Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society
Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Sakisaka S, Kobayashi E, Tanaka E, Inomata Y, Kawasaki S, Shimada M, Kokudo N, Egawa H, Ohdan H, Uemoto S
Am J Transplant, 18(3), 659-668, Mar. 2018 - 長期経過加療中の非肝硬変期に肝細胞癌を合併した原発性胆汁性胆管炎の２例
杉浦亜弓, 城下智, 山下裕騎, 木村岳史, 山崎智生, 藤森尚之, 小松通治, 松本晶博, 小林翔太, 梅村武司, 田中榮司
信州医学雑誌, 66(1), 39-49, 10 Feb. 2018
- Genetics and epigenetics in the pathogenesis of primary biliary cholangitis
Joshita S, Umemura T, Tanaka E, Ota M
Clin J Gastroenterol, 11(1), 11-18, Feb. 2018 - Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy
Matsumoto A, Nishiguchi S, Enomoto H, Kang JH, Tanaka Y, Shinkai N, Kurosaki M, Enomoto M, Kanda T, Yokosuka O, Yatsuhashi H, Nagaoka S, Okuse C, Kagawa T, Mine T, Takaguchi K, Saito S, Hino K, Ikeda F, Sakisaka S, Morihara D, Miyase S, Tsuge M, Chayama K, Hiramatsu N, Suzuki Y, Murata K, Tanaka E
J Gastroenterol, 53(2), 247-257, Feb. 2018 - Induction of IFN-lambda3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
Gut, 67(2), 362-371, Feb. 2018 - Salmonella Enteritidis cholecystitis with chronic granulomatous disease
Yamashita Y, Kimura T, Tanaka N, Yazaki M, Itagaki T, Joshita S, Umemura T, Matsumoto A, Mori H, Wada S, Tanaka E
IDCases, 12, 49-52, 2018 - Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population
Saito H, Hirayama A, Umemura T, Joshita S, Mukawa K, Suga T, Tanaka E, Ota M
PLOS ONE, 13(4), e0195778, 2018 - Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Ota M, Tanaka E
PLOS ONE, 13(4), e0195632, 2018 - Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients
Umemura T, Joshita S, Hamano H, Yoshizawa K, Kawa S, Tanaka E, Ota M
J Hum Genet, 62(11), 963-967, Nov. 2017 - Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury
Fujimori N, Komatsu M, Tanaka N, Iwaya M, Nakano H, Sugiura A, Yamazaki T, Shibata S, Iwaya Y, Muraki T, Ichikawa Y, Kimura T, Joshita S, Umemura T, Matsumoto A, Tanaka E
Clin J Gastroenterol, 10(5), 452-458, Oct. 2017 - Survival in patients with Child-Pugh class C cirrhosis: Analysis of the liver transplant registry in Japan
Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y, The Assessment Committee of Indication for Transplantation
Hepatol Res, 47(11), 1155-1164, Oct. 2017 - Association between lower air pressure and the onset of ischemic colitis: a case-control study
Kimura T, Shinji A, Tanaka N, Koinuma M, Yamaura M, Nagaya T, Joshita S, Komatsu M, Umemura T, Horiuchi A, Wada S, Tanaka E
Eur J Gastroenterol Hepatol, 29(9), 1071-1078, Sep. 2017 - 【ウイルス肝炎のすべて】血液伝播するウイルス肝炎 B型肝炎 B型肝炎に対する核酸アナログ/インターフェロン併用療法
梅村武司, 田中榮司
医学のあゆみ, 262(14), 1336-1340, Sep. 2017 - Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M
Liver Int, 37(6), 897-905, Jun. 2017 - Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
Sugiura A, Wada S, Mori H, Kimura T, Matsuda Y, Tanaka N, Tanaka E, Kiyosawa K
Case Rep Gastroenterol, 11(2), 305-311, May 2017 - Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody
Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
J Gastroenterol, 52(3), 376-384, May 2017 - 【混合型肝癌をめぐる混乱の終焉を目指して】 混合型肝癌[ICD-0 code 8180/3(WHO2010)]の画像診断
上田和彦, 平塚真生子, 松枝清, 高澤豊, 笹平直樹, 齋浦明夫, 田中榮司, 宮川眞一
肝・胆・膵, 74(5), 761-767, May 2017 - 6年間に40回以上の内視鏡的バルーン拡張術を要した食道慢性GVHDの1例
平山敦大, 菅智明, 大野和幸, 小林惇一, 齊藤博美, 日原 優, 横田有紀子, 伊東哲宏, 中村麗那, 北畠央之, 田中景子, 岡村卓磨, 田中榮司
ENDOSCOPIC FORUM for digestive disease, 33(1), 51, May 2017 - Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Igarashi K, Tanaka E
Sci Rep, 7, 46705, Apr. 2017 - Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection
Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
Hepatol Res, 47(5), 405-418, Apr. 2017 - 関節リウマチ治療中に発症した悪性リンパ腫の1例
酒井均, 川上徹, 須藤祐里子, 仁科さやか, 妹尾紀子, 中澤英之, 田中榮司
長野県医学会雑誌, 47, 101, Mar. 2017 - IgG4関連疾患における悪性腫瘍発症
浅野純平, 渡邉貴之, 北野真希子, 中村晃, 伊藤哲也, 田中榮司
長野県医学会雑誌, 47, 26-27, Mar. 2017 - 【内科領域におけるウイルス感染症〜ウイルス感染症に対する最新の知識と治療〜】 日常遭遇することの多いウイルス感染症 肝炎領域 B型肝炎
田中榮司
日本内科学会雑誌, 106(3), 422-427, Mar. 2017 - Association between endotoxemia and histological features of nonalcoholic fatty liver disease
Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Koinuma M, Sano K, Aoyama T, Tanaka E
World J Gastroenterol, 23(4), 712-722, Jan. 2017 - The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study
Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O
J Gastroenterol, 52(1), 113-122, Jan. 2017 - 【エキスパートが教える薬の使い方×エビデンスの調べ方】 (第1章)よくある疾患に対する薬の使い分け 肝炎
梅村武司, 田中榮司
薬事, 59(2), 280-284, Jan. 2017 - The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.
Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O
J Gastroenterol, 52(1), 113-122, Jan. 2017
- Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
Joshita S, Umemura T, Tanaka E, Ota M
J Immunol Res, 3073504, 2017 - Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis
Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O
Clin J Gastroenterol, 10(1), 73-78, Dec. 2016 - Survival in patients with Child-Pugh class C cirrhosis: analysis of the liver transplant registry in Japan.
Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y
Hepatol Res, in press, Dec. 2016 - Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up
Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E
Clin J Gastroenterol, 10(1), 79-85, Nov. 2016 - Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society.
Umeshita K, Inomata Y, Furukawa H, Kasahara M, Kawasaki S, Kobayashi E, Kokudo N, Sakisaka S, Shimada M, Tanaka E, Uemoto S; Japanese Liver Transplantation Society.
Hepatol Res, 46(12), 1171-1186, Nov. 2016 - Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
Gut, in press, Oct. 2016 - Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations.
Mori KI, Matsumoto A, Maki N, Ichikawa Y, Tanaka E, Yagi S
BMC Microbiol, 16(1), 224, Sep. 2016 - Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.
Fujimori N, Tanaka N, Shibata S, Sano K, Yamazaki T, Sekiguchi T, Kitabatake H, Ichikawa Y, Kimura T, Komatsu M, Umemura T, Matsumoto A, Tanaka E
Hepatol Res, 46(10), 1019-27, Sep. 2016 - A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.
Yamazaki T, Iwaya Y, Iwaya M, Watanabe T, Seki A, Ochi Y, Hara E, Sekiguchi T, Hosaka N, Arakura N, Tanaka E, Hasebe O
Clin J Gastroenterol, 9(4), 222-7, Aug. 2016 - Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan.
Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, Maejima T, Ota M
Hepatol Res, 46(9), 878-83, Aug. 2016 - Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
Shibata S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, 46(9), 884-9, Aug. 2016 - Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.
Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
J Gastroenterol, in press, Jul. 2016 - Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan.
Umemura T, Joshita S, Yamazaki T, Komatsu M, Katsuyama Y, Yoshizawa K, Tanaka E, Ota M
Sci Rep, 6, 29770, Jul. 2016 - Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
Shibata S, Joshita S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Komatsu M, Matsumoto A, Tanaka E
Springerplus, 5(1), 998, Jul. 2016 - Case of Barrett's adenocarcinoma with marked endoscopic morphological changes in Barrett's esophagus over a long follow-up period of 15 years.
Iwaya Y, Yamazaki T, Watanabe T, Seki A, Ochi Y, Hara E, Arakura N, Tanaka E, Hasebe O
Dig Endosc, 28(5), 607-10, Jul. 2016 - Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
Hepatol Res, in press, Jun. 2016 - Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C.
Shibata S, Umemura T, Komatsu M, Tanaka E
Hepatology, 63(6), 2063-4, Jun. 2016 - A Case of Esophageal Hemangioma Successfully Treated by Endoscopic Injection Sclerotherapy
Suga Tomoaki, Okamura Takuma, Iwaya Yugo, Ito Tetsuya, Arakura Norikazu, Umemura Takeji, Tanaka Eiji
信州医学雑誌, 64(2), 75-78, 10 Apr. 2016 - Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.
Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H, Yokosuka O, Koike K, Kurosaki M, Izumi N, Korenaga M, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Sakamoto N, Yamamoto K, Tamori A, et al
Sci Rep, 6, 24767, Apr. 2016 - Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, 47(2), 226-233, Mar. 2016 - The loop-forming method as a useful technique to rotate the endoscopic insertion tube shaft.
Suga T, Okamura T, Arakura N, Tanaka E
Endosc Int Open, 4(2), E170-4, Feb. 2016 - JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.
Asahina Y, Izumi N, Hiromitsu K, Kurosaki M, Koike K, Suzuki F, Takikawa H, Tanaka A, Tanaka E, Tanaka Y, Tsubouchi H, Hayashi N, Hiramatsu N, Yotsuyanagi H
Hepatol Res, 46(2), 129-65, Feb. 2016 - Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease.
Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M
Dis Markers, 2016, 6485343, 2016 - Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine.
Daikuhara S, Uehara T, Higuchi K, Hosaka N, Iwaya M, Maruyama Y, Matsuda K, Arakura N, Tanaka E, Ota H
Acta Histochem Cytochem, 48(6), 193-204, Dec. 2015 - Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.
Matsumoto A, Yatsuhashi H, Nagaoka S, Suzuki Y, Hosaka T, Tsuge M, Chayama K, Kanda T, Yokosuka O, Nishiguchi S, Saito M, Miyase S, Kang JH, Shinkai N, Tanaka Y, Umemura T, Tanaka E
Hepatol Res, 45(12), 1195-202, Dec. 2015 - A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm?
Muraki T, Uehara T, Sano K, Oota H, Yoshizawa A, Asaka S, Tateishi A, Otsuki T, Shingu K, Matoba H, Kobayashi S, Ichimata S, Watanabe T, Itou T, Tanaka E
Pathol Res Pract, 211(12), 1034-9, Dec. 2015 - Clinicopathological characterisation of duodenal adenocarcinoma with high CD44 variant 9 expression.
Maruyama Y, Uehara T, Daikuhara S, Kobayashi Y, Nakajima T, Matsumoto A, Tanaka E, Ota H
PATHOLOGY, 47(7), 647-52, Dec. 2015 - A case of acquired hemophilia A diagnosed after percutaneous endoscopic gastrostomy.
Okamura T, Komatsu M, Ito A, Ito T, Suga T, Arakura N, Sakai H, Tanaka E
Clin J Gastroenterol, 8(5), 290-3, Oct. 2015 - Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
Yamada S, Okamura T, Kobayashi S, Tanaka E, Nakayama J
J Gastroenterol Hepatol, 30(10), 1478-84, Oct. 2015 - Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.
Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Takasaki H, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, et al
Clin Infect Dis, 61(5), 719-29, Sep. 2015 - Primary hepatocellular carcinoma in a patient with neurofibromatosis type I.
Kimura T, Tanaka N, Umemura T, Tanaka E
Liver Int, 35(8), 2057-8, Aug. 2015 - Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis.
Umemura T, Shibata S, Sekiguchi T, Kitabatake H, Nozawa Y, Okuhara S, Kimura T, Morita S, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, 45(7), 739-44, Jul. 2015 - Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M
PLOS ONE, 10(6), e0131658, Jun. 2015 - Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E
Am J Gastroenterol, 110(6), 857-64, Jun. 2015 - Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T
Biochim Biophys Acta, 1852(3), 473-81, Mar. 2015 - Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E
BBA Clin, 3, 168-74, Feb. 2015 - Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E
World J Gastroenterol, 21(2), 541-8, Jan. 2015 - Superficially located enlarged lymphoid follicles characterise nodular gastritis.
Okamura T, Sakai Y, Hoshino H, Iwaya Y, Tanaka E, Kobayashi M
PATHOLOGY, 47(1), 38-44, Jan. 2015 - Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M
PLOS ONE, 9(6), e100565, Jun. 2014
- Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B
Tanaka, E; Matsumoto, A
Hepatol Res, 44(1), 1-8, Jan. 2014 - STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
Joshita, S; Umemura, T; Nakamura, M; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Yoshizawa, K; Ishibashi, H; Tanaka, E; Ota, M
DISEASE MARKERS, 2014, 727393, 2014 - Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
Joshita, S; Shirahata, K; Yazaki, Y; Okaniwa, S; Nakamura, Y; Kimura, T; Noami, S; Horigome, R; Yagi, H; Ito, N; Yamazaki, A; Akahane, Y; Umemura, T; Yoshizawa, K; Tanaka, E; Ota, M
HEPATOLOGY RESEARCH, 43(7), 801-807, Jul. 2013 - Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography
Muraki, T; Arakura, N; Kodama, R; Yoneda, S; Maruyama, M; Itou, T; Watanabe, T; Maruyama, M; Matsumoto, A; Kawa, S; Tanaka, E
DIGESTIVE ENDOSCOPY, 25(2), 189-196, Mar. 2013 - Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
Morita, S; Joshita, S; Umemura, T; Katsuyama, Y; Kimura, T; Komatsu, M; Matsumoto, A; Yoshizawa, K; Kamijo, A; Yamamura, N; Tanaka, E; Ota, M
HUMAN IMMUNOLOGY, 74(2), 219-222, Feb. 2013 - Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy
Sekiguchi, N; Joshita, S; Yoshida, T; Kurozumi, M; Sano, K; Nakagawa, M; Ito, T; Matsushita, T; Komatsu, D; Komatsu, M; Ito, T; Umemura, T; Ikeda, S; Kadoya, M; Ishida, F; Tanaka, E
INTERNAL MEDICINE, 52(17), 1903-1908, 2013 - Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S
J Gastroenterol, 47(9), 1006-1013, Sep. 2012 - 2011 Japanese society for dialysis therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients
Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T
Ther Apher Dia, 16(4), 289-310, Aug. 2012 - Helicobacter pylori-Negative Primary Rectal MALT Lymphoma: Complete Remission after Radiotherapy
Okamura T, Suga T, Iwaya Y, Ito T, Yokosawa S, Arakura N, Ota H, Tanaka E
Case Rep Gastroenterol, 6(2), 319-27, Jul. 2012 - No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
Sawai H, Nishida N, Mbarek H, Matsuda K, Mawatari Y, Yamaoka M, Hige S, Kang J. H, Abe K, Mochida S, Watanabe M, Kurosaki M, Asahina Y, Izumi N, Honda M, Kaneko S, Tanaka E, Matsuura K, Itoh Y, Mita E, Korenaga M, Hino K, Murawaki Y, Hiasa Y, Ide T, Ito K, Sugiyama M, Ahn S. H, Han K. H, Park J. Y, Yuen M. F, Nakamura Y, Tanaka Y, Mizokami M, Tokunaga K
BMC Med Genet, 13, 47, Jun. 2012 - Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean
Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn S. H, Park J. Y, Hige S, Kang J. H, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M
PLOS ONE, 7(6), e39175, Jun. 2012 - Hepatic Cerebroside Sulfotransferase Is Induced by PPARalpha Activation in Mice
Kimura T, Nakajima T, Kamijo Y, Tanaka N, Wang L, Hara A, Sugiyama E, Tanaka E, Gonzalez Frank J, Aoyama T
PPAR Res, 174932, May 2012 - Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-alpha inhibitors
Tanaka E, Urata Y
Hepatol Res, 42(4), 333-339, Apr. 2012 - Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
Joshita, Satoru; Umemura, Takeji; Katsuyama, Yoshihiko; Ichikawa, Yuki; Kimura, Takefumi; Morita, Susumu; Kamijo, Atsushi; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Kamijo, Nozomi; Ota, Masao; Tanaka, Eiji
HUMAN IMMUNOLOGY, 73(3), 298-300, Mar. 2012 - Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H
Hepatol Res, 42(2), 139-149, Feb. 2012 - Long-term outcome of japanese patients with type 1 autoimmune hepatitis
Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M, Katsuyama Y, Kiyosawa K, Abe M, Onji M
56(2), 668-676, Feb. 2012 - Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis
Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E
Hepatology, 55(2), 506-511, Feb. 2012 - Assessment of safety of using antithrombotic agents during esophagogastroduodenoscopy: rationale and design of the ASAMA Study
Kasai H, Suga T, Ikeda U, Yoshioka J, Tanaka E, Akamatsu T, for the ASAMA study Investigators
Shinshu Medical Journal, 60(3), 143-148, 2012 - Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening.
Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E
J Gastroenterol, 46(12), 1353-1360, Dec. 2011 - Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients
Aiba Y, Nakamura M, Joshita S, Inamine T, Komori A, Yoshizawa K, Umemura T, Horie H, Migita K, Yatsuhashi H, Nakamuta M, Fukushima N, Saoshiro T, Hayashi S, Kouno H, Ota H, Muro T, Watanabe Y, Nakamura Y, Komeda T, Shimada M, Masaki N, Komatsu T, Yagura M, Sugi K, Koga M, Tsukamoto K, Tanaka E, Ishibashi H, P. B. C. Study Group in NHOSLJ
J Gastroenterol, 46(10), 1203-1212, Oct. 2011 - Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C.
Umemura T, Joshita S, Yoneda S, Katsuyama Y, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E
Antivir Ther, 16(7), 1073-1080, Oct. 2011 - Primary gastric diffuse large B-cell lymphoma with orbital involvement: diagnostic usefulness of 18F-fluorodeoxyglucose positron emission tomography.
Iwaya Y, Takenaka K, Akamatsu T, Yamada Y, Haba S, Matsuda K, Nakazawa H, Muraki T, Kaneko Y, Ito T, Sano K, Arakura N, Tanaka E, Ishida F
Intern Med, 50(18), 1953-1956, Sep. 2011 - Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C
Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N, Enomoto N, Yatsuhashi H, Nishiguchi S, Hino K, Hige S, Itoh Y, Tanaka E, Mochida S, Honda M, Hiasa Y, Koike A, Sugauchi F, Kaneko S, Izumi N, Tokunaga K, Mizokami M
HUMAN MOLECULAR GENETICS, 20(17), 3507-3516, Sep. 2011 - Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy
Ichikawa-Yamada Y, Joshita S, Tsukahara Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
HEPATOLOGY RESEARCH, 41(9), 904-909, Sep. 2011 - Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy
Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamaura T, Nagaya T, Komatsu M, Sano K, Miyagawa S, Aoyama T, Tanaka E
JOURNAL OF GASTROENTEROLOGY, 46(6), 758-768, Jun. 2011 - Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Yoneda S, Umemura T, Joshita S, Ichijo T,Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E
HEPATOLOGY RESEARCH, 41(6), 587-593, Jun. 2011 - Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b
Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Yuki NS, Itsui Y, Azuma S, Kakinuma S, Hige S, Itoh Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M
JOURNAL OF MEDICAL VIROLOGY, 83(5), 871-878, May 2011 - Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
Kamijo A, Yoshizawa K, Joshita S, Yoneda S, Umemura T, Ichijo T, Matsumoto A, Ota M, Tanaka E
HEPATOLOGY RESEARCH, 41(4), 350-357, Apr. 2011 - Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
Yoneda, Suguru; Umemura, Takeji; Katsuyama, Yoshihiko; Kamijo, Atsushi; Joshita, Satoru; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Ota, Masao; Tanaka, Eiji
JOURNAL OF INFECTIOUS DISEASES, 203(8), 1087-1095, Apr. 2011 - Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009
Yokosuka O, Kurosaki M, Imazeki F, Arase Y, Tanaka Y, Chayama K, Tanaka E, Kumada H, Izumi N, Mizokami M, Kudo M
HEPATOLOGY RESEARCH, 41(1), 1-21, Jan. 2011 - Clinical significance of immunoglobulin G4-associated autoimmune hepatitis
Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, Kiyosawa K, Ota M, Kawa S, Nakanuma Y, Tanaka E
JOURNAL OF GASTROENTEROLOGY, 46(SUPPL 1), 48-55, Jan. 2011 - A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture
Nozawa Y, Joshita S, Fukushima M, Sugiyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
INTERNAL MEDICINE, 50(17), 1815-1819, 2011 - Severe hepatic encephalopathy and decrease in enhancement of hepatocellular carcinoma treated with sorafenib
Kimura T, Umemura T, Ichijo T, Yamamura N, Tanaka E
International Journal of Case Reports and Images, 1(4), 16-18, Dec. 2010 - Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
Hatta T, Fujinaga Y, Kadoya M, Ueda H, Murayama H, Kurozumi M, Ueda K, Komatsu M, Nagaya T, Joshita S, Kodama R, Tanaka E, Uehara T, Sano K, Tanaka N
JOURNAL OF GASTROENTEROLOGY, 45(12), 1263-1271, Dec. 2010 - Small Bowel Tissue Concentration of Rebamipide: Study of Two Dosages in Healthy Subjects
Akamatsu T, Nagaya T, Ichikawa S, Sudo T, Takeda R, Takenaka K, Kodama R, Ito T, Arakura N, Tanaka E
Journal of Clinical Biochemistry and Nutrition, 47(3), 256-260, Nov. 2010 - Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice
Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T
Biochemical Pharmacology, 80(10), 1601-1612, Nov. 2010 - Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Nakayama J, Tanaka E, Aoyama T
JOURNAL OF HEPATOLOGY, 53(4), 724-731, Oct. 2010 - Chronic Gastritis in the Setting of Autoimmune Pancreatitis
Uehara T, Hamano H, Kawa S, Sano K, Oki K, Kobayashi Y, Nagaya T, Akamatsu T, Kurozumi M, Fujinaga Y, Tanaka E, Honda T, Ota H
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 34(9), 1241-1249, Sep. 2010 - Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients
Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Nakamura, Minoru; Ishibashi, Hiromi; Ota, Masao
JOURNAL OF HEPATOLOGY, 53(3), 537-541, Sep. 2010 - Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment
Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y
DIGESTIVE DISEASES AND SCIENCES, 55(7), 2095-2101, Jul. 2010 - Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice.
Nakajima T, Tanaka N, Li G, Hu R, Kamijo Y, Hara A, Aoyama T
Redox Rep, 15(3), 123-130, Jul. 2010 - Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Tsutsui, Masaru; Tanaka, Naoki; Kawakubo, Masatomo; Sheena, Yo; Horiuchi, Akira; Komatsu, Michiharu; Nagaya, Tadanobu; Joshita, Satoru; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji; Sano, Kenji
JOURNAL OF CLINICAL GASTROENTEROLOGY, 44(6), 440-447, Jul. 2010 - Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits
Tsuruta, Goro; Tanaka, Naoki; Hongo, Minoru; Komatsu, Michiharu; Horiuchi, Akira; Hamamoto, Kaeko; Iguchi, Chieko; Nakayama, Yoshiko; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji
JOURNAL OF GASTROENTEROLOGY, 45(6), 666-672, Jun. 2010 - A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients
Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Ota, Masao
HUMAN IMMUNOLOGY, 71(5), 520-524, May 2010 - Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya, T.; Tanaka, N.; Komatsu, M.; Joshita, S.; Umemura, T.; Ichijo, T.; Matsumoto, A.; Yoshizawa, K.; Aoyama, T.; Tanaka, E.
JOURNAL OF HEPATOLOGY, 52(Suppl. 1), S373-S374, Apr. 2010 - A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry
Joshita, Satoru; Nakazawa, Koh; Koike, Shoichiro; Kamijo, Atsushi; Matsubayashi, Kiyoshi; Miyabayashi, Hideharu; Furuta, Kiyoshi; Kitano, Kiyoshi; Yoshizawa, Kaname; Tanaka, Eiji
JOURNAL OF KOREAN MEDICAL SCIENCE, 25(3), 476-480, Mar. 2010 - Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y
HEPATOLOGY RESEARCH, 40(1), 8-13, Jan. 2010 - Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y
HEPATOLOGY RESEARCH, 40(1), 1-7, Jan. 2010 - Usefulness of double balloon enteroscopy and video capsule endoscopy for the diagnosis and management of primary follicular lymphoma of the gastrointestinal tract in its early stages
Akamatsu T, Kaneko Y, Ota H, Miyabayashi H, Arakura N, Tanaka E
DIGESTIVE ENDOSCOPY, 22(1), 33-38, Jan. 2010 - A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
Joshita, Satoru; Yoshizawa, Kaname; Sano, Kenji; Kobayashi, Satoshi; Sekiguchi, Tomohiro; Morita, Susumu; Kamijo, Atsushi;Komatsu, Michiharu; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Tanaka, Eiji
INTERNAL MEDICINE, 49(11), 991-994, 2010 - CLINICAL AND VIROLOGICAL FEATURES OF PATIENTS WITH FULMINANT HEPATIC FAILURE DUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS
Umemura, T.; Kiyosawa, K.; Tanaka, E.; Grp, Japan Novo Hepatitis B. Res
JOURNAL OF HEPATOLOGY, 52(Suppl. 1), S286-S286, 2010 - Comparison of hepatitis B virus DNA, RNA, and core related antigen as predictors of lamivudine resistance in patients with chronic hepatitis B
Matsumoto A, Maki N, Yoshizawa K, Umemura T, Joshita S, Tanaka E
ShinshuMed J, 58(4), 153-162, 2010 - Combination Chemotherapy with Low-dose 5-FU, Cisplatin, and Gemcitabine for Gemcitabine-Refractory Pancreatic Cancer
Norikazu ARAKURA, Osamu HASEBE, Yasuhide OCHI, Hideaki HAMANO, Eiji TANAKA, Shigeyuki KAWA
信州医学雑誌, 57(6), 247-253, Dec. 2009 - Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
Okanoue, Takeshi; Itoh, Yoshito; Hashimoto, Hiroaki; Yasui, Kohichiroh; Minami, Masahito; Takehara, Tetsuo; Tanaka, Eiji; Onji, Morikazu; Toyota, Joji; Chayama, Kazuaki; Yoshioka, Kentaro; Izumi, Namiki; Akuta, Norio; Kumada, Hiromitsu
JOURNAL OF GASTROENTEROLOGY, 44(9), 952-963, Sep. 2009 - A case of well-differentiated cholangiolocellular carcinoma visualizedwith contrast-enhanced ultrasonography using Sonazoid
Joshita, Satoru; Ichijo, Tetsuya; Suzuki, Fumitaka; Yokoyama, Takahide; Sugiyama, Yukiko; Fukushima, Mana; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Yoshizawa, Kaname; Miyagawa, Shinichi; Tanaka, Eiji
HEPATOLOGY RESEARCH, 39(2), 207-212, Feb. 2009 - Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
Arakura, Norikazu; Ozaki, Yayoi; Yamazaki, Sachie; Ueda, Kazuhiko; Maruyama, Masafumi; Chou, Yoshimi; Kodama, Ryo; Takayama, Mari; Hamano, Hideaki; Tanaka, Eiji; Kawa, Shigeyuki
INTERNAL MEDICINE, 48(21), 1885-1888, 2009 - Primitive Neuroectodermal Tumor as a Differential Diagnosis of CD56-Positive Tumors in Adults
Nagaya, Tadanobu; Tanaka, Naoki; Kamijo, Atsushi; Joshita, Satoru; Nakazawa, Koh; Miyabayashi, Hideharu; Yoneda, Suguru; Ito, Tetsuya; Komatsu, Michiharu; Tanaka, Eiji; Kitano, Kiyoshi
INTERNAL MEDICINE, 48(15), 1267-1272, 2009 - Pancreaticobiliary Fistula Evident after ESWL Treatment of Pancreatolithiasis
Arakura, N; Ozaki, Y; Maruyama, M; Chou, Y; Kodama, R; Takayama, M; Hamano, H; Tanaka, E; Kawa, S
INTERNAL MEDICINE, 48(7), 545-549, 2009 - Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
Tanaka, N; Sano, K; Horiuchi, A; Tanaka, E; Kiyosawa, K; Aoyama, T
JOURNAL OF CLINICAL GASTROENTEROLOGY, 42(4), 413-418, 2008 - Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
Umemura, T; Tanaka, E; Kiyosawa, K; Kumada, H
CLINICAL INFECTIOUS DISEASES, 47(5), E52-E56, 2008 - Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
Tanaka, N; Nagaya, T; Komatsu, M; Horiuchi, A; Tsuruta, G; Shirakawa, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Aoyama, T; Kiyosawa, K; Tanaka, E
LIVER INTERNATIONAL, 28(8), 1104-1111, 2008 - Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C
Umemura, T; Muto, H; Tanaka, E; Matsumoto, A; Ichijo, T; Yoshizawa, K; Akamatsu, T; Kiyosawa, K
JOURNAL OF VIRAL HEPATITIS, 14(1), 48-54, 2007 - Lack of association between FCRL3 and Fc gamma RII polymorphisms in Japanese type 1 autoimmune hepatitis
Umemura, T; Ota, M; Yoshizawa, K; Katsuyama, Y; Ichijo, T; Tanaka, E; Kawa, S; Kiyosawa, K
Clinical Immunology, 122(3), 338-342, 2007 - Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
Sugauchi, F; Orito, E; Ohno, T; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Ichida, T; Izumi, N; Inoue, K; Hoshino, H; Iino, S; Yotsuyanagi, H; Kakumu, S; Tomita, E; Okanoue, T; Nishiguchi, S; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Miyakawa, Y; Ueda, R; Mizokami, M
HEPATOLOGY RESEARCH, 36(2), 107-114, 2006 - A genome-wide DNA microsatellite association study of autoimmune hepatitis type 1 in Japan
Yoshizawa, K; Yokosawa, S; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Matsumoto, A; Tanaka, E; Kiyosawa, K
Hepatology, 44(4), 228A-228A, 2006 - Influence of hepatitis B virus genotypes as well as precore and core-promoter mutations on fulminant outcome of acute infection
Sugauchi, F; Orito, E; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Yotsuyanagi, H; Iino, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Izumi, N; Inoue, K; Kakumu, S; Tomita, E; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Okanoue, T; Nishiguchi, S; Miyakawa,Y; Mizokami, M
Hepatology, 44(4), 539A-539A, 2006 - Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection
Ozasa, A; Tanaka, Y; Orito, E; Sugiyama, M; Kang, JH; Hige, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Okada, S; Tokita, H; Asahina, Y; Inoue, K; Kakumu, S; Okanoue, T; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sakugawa, H; Miyakawa, Y; Ueda, R; Mizokami, M
Hepatology, 44(2), 326-334, 2006 - Timing of interferon therapy and sources of infection in patients with acute hepatitis C
Ogata, K; Ide, T; Kumashiro, R; Kumada, H; Yotsuyanagi, H; Okita, K; Akahane, Y; Kaneko, S; Tsubouchi, H;Tanaka, E; Moriwaki, H; Nishiguchi, S; Kakumu, S; Mizokami, M; Iino, S; Sata, M
HEPATOLOGY RESEARCH, 34(1), 35-40, 2006 - Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy
Rokuhara, A; Matsumoto, A; Tanaka, E; Umemura, T; Yoshizawa, K; Kimura, T; Maki, N; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 41(8), 785-790, 2006 - Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
Tanaka, N; Tanaka, E; Sheena, Y; Komatsu, M; Okiyama, W; Misawa, N; Muto, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Horiuchi, A; Kiyosawa, K
LIVER INTERNATIONAL, 26(8), 956-963, 2006 - Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region
Kitano, K; Kobayashi, H; Hanamura, M; Furuta, K; Ueno, M; Rokuhara, A; Tanaka, E; Umemura, T; Kiyosawa, K
EUROPEAN JOURNAL OF HAEMATOLOGY, 77(3), 255-258, 2006 - Laparoscopic findings in patients with nonalcoholic steatohepatitis
Tanaka, N; Ichijo, T; Okiyama, W; Mutou, H; Misawa, N; Matsumoto, A; Yoshizawa, K; Tanaka, E; Kiyosawa, K
LIVER INTERNATIONAL, 26(1), 32-38, 2006 - Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance
Tanaka, E; Matsumoto, A; Suzuki, F; Kobayashi, M;Mizokami, M; Tanaka, Y; Okanoue, T; Minami, M; Chayama, K; Imamura, M; Yatsuhashi, H; Nagaoka, S; Yotsuyanagi, H; Kawata, S; Kimura, T; Maki, N; Iino, S; Kiyosawa, K
LIVER INTERNATIONAL, 26(1), 90-96, 2006 - Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics
Misawa, N; Matsumoto, A; Tanaka, E; Rokuhara, A; Yoshizawa, K; Umemura, T; Maki, N; Kimura, T; Kiyosawa, K
JOURNAL OF MEDICAL VIROLOGY, 78(1), 68-73, 2006 - Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
Gad A, Tanaka E, Matsumoto A, Wahab MA, Serwah Ael-H, Attia F, Ali K, Hassouba H, el-Deeb Ael-R, Ichijyo T, Umemura T, Muto H, Yoshizawa K, Kiyosawa K
WorldJ Gastroenterol, 14, 6607-6612, 2005 - Ethnicity affects the diagnostic validity of alpha-fetoprotein in hepatocellular carcinoma
Gad A, Tanaka E, Matsumoto A, Serwah Ael-H , Attia F , Hassan A, Ali K , Abbas A, el-Deeb Ael- , Sun X, Umemura T, Ichijyo T, Ehara T, Yoshizawa K, Kiyosawa K
Asia-Pacific Journal of clinical oncology, 1, 64-70, 2005 - 当科における肝細胞癌に対するラジオ波焼灼術の実態
一條哲也，沖山 洋，武藤英知，三沢倫子，梅村武司，松本晶博，吉澤 要，田中榮司，清澤研道
長野県医学会雑誌, 35, 38-39, 2005 - 信州大学病院において－ウィルス性肝炎移植の現状と問題点－
田中榮司
今日の移植, 18, 216-219, 2005 - E型肝炎ウィルス（HEV）マーカー 広範囲血液・尿化学検査，免疫学的検査
田中榮司
日本臨床, 63, 421-423, 2005 - 【生活習慣病と非アルコール性脂肪肝炎(NASH)】脂肪肝と肝移植
田中直樹，田中榮司，清澤研道
Progress inMedicine, 25, 1657-1660, 2005 - 【C型肝炎の最新治療 治療方針のたて方と治療効果】治療方針とその効果 高ウイルス量の患者への治療方針と効果
松本晶博，田中榮司，清澤研道
消化器の臨床, 8, 180-183, 2005 - ウィルス性肝炎の治療の最前線
四柳 宏，田中榮司，横須賀 収
ヒューマンサイエンス, 16, 4-10, 2005 - Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients
Yagi S, Mori K, Tanaka E, Matsumoto A, Sunaga F, Kiyosawa K, Yamaguchi K
J Med Virol, 77(3), 399-413, 2005 - Identification and quantitative analysis of a 22-KDA precore protein lacking C-terminal arginine-rich domain in hepatitis B virus DNA-negative Dane particles.
Kimura, T; Ohue, C; Ohno, N; Terada, N; Ohno, S; Akinori, R; Matsumoto, A; Tanaka, E; Kiyosawa, K; Maki, N
Hepatology, 42(4), 708A-708A, 2005 - Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan
Orito, E; Sugauchi, F; Tanaka, Y; Ichida, T; Sata, M; Tanaka, E; Okanoue, T; Sakugawa, H; Watanabe, H; Miyakawa, H; Nishiguchi, S; Kumada, H; Ueda, R; Mizokami, M
INTERVIROLOGY, 48(4), 239-245, 2005 - Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection
Higashi, K; Tsukiyama-Kohara, K; Tanaka, T; Tanaka, E; Kiyosawa, K; Kohara, M
ARCHIVES OF VIROLOGY, 150(5), 883-898, 2005 - Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection
Rokuhara A, Sun X, Tanaka E, Kimura T, Matsumoto A, Yao D, Yin L, Wang N, Maki N, Kiyosawa K
J Gastroenterol Hepatol, 20(11), 1726-1730, 2005 - Nucleotide mutations associated with hepatitis B e antigen negativity
Sun X, Rokuhara A, Tanaka E, Gad A, Mutou H, Matsumoto A, Yoshizawa K, Kiyosawa K
J Med Virol, 76(2), 170-175, 2005 - Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis
Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K
J Hepatol, 42(4), 578-584, 2005 - Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients
Matsumoto, A; Tanaka, E; Rokuhara, A; Kiyosawa, K; Kumada, H; Omata, M; Okita, K; Hayashi, N; Okanoue, T; Iino, S; Tanikawa, K
HEPATOLOGY RESEARCH, 32(3), 173-184, 2005 - Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan
Tanaka, E; Matsumoto, A; Takeda, N; Li, TC; Umemura, T; Yoshizawa, K; Miyakawa, Y; Miyamura, T; Kiyosawa, K
JOURNAL OF VIRAL HEPATITIS, 12(4), 439-442, 2005 - Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
Kimura, T; Ohno, N; Terada, N; Rokuhara, A; Matsumoto, A; Yagi, S; Tanaka, E; Kiyosawa, K; Ohno, S; Maki, N
JOURNAL OF BIOLOGICAL CHEMISTRY, 280(23), 21713-21719, 2005 - Wilson病の治療と発症予防
梅村武司，田中栄司，清澤研道
肝臓, 45, 459-462, 2004 - SENウイルス(SEN V)の分子生物学
梅村武司，田中栄司
日本臨床, 62, 596-597, 2004 - 我が国におけるSENウイルス感染の状況とその背景
梅村武司，田中栄司
日本臨床, 62, 602-605, 2004 - C型肝炎ウイルス 特殊型C型肝炎の臨床特論 HCV,HGV重複感染の疫学
折井幸司，田中栄司，清澤研道
日本臨床, 62, 677-681, 2004 - B型肝炎の治療 B型肝炎診療Q&A HBe抗原陽性，高ウイルス量のB型慢性肝炎症例にいかに対処するか
田中栄司
臨床医, 30, 1601-1603, 2004 - B型慢性肝炎 HBe抗原陰性，肝機能異常を繰り返す症例に対する冶療
田中栄司
肝臓, 45, 397-401, 2004 - C型肝炎 最近の動向
田中栄司
看護技術, 50, 11-15, 2004 - C型肝炎ウイルス(HCV) HCV抗原測定法 HCVコア抗原測定法とその臨床的有用性
田中栄司
日本臨床, 62, 208-213, 2004 - E型肝炎の概論
田中栄司
日本臨床, 62, 536-541, 2004 - B型肝炎の治療up to date ラミブジン治療は肝発癌過程を修飾するか
松本晶博，田中栄司，清澤研道
臨床消化器内科, 191, 1507-1512, 2004 - C型肝炎ウイルス(HCV) C型慢性肝炎 予後に関連する因子の解析臨床検査データ
松本晶博，田中栄司，清澤研道
日本臨床, 62, 430-433, 2004 - Hepatitis B virus covalently closed circuler DNAの定療法と臨床的意義
向出雅一，松本晶博，六波羅明紀，田中栄司，竹村一男，兒崎隆純，引地一昌，清澤研道
SRL宝函, 28, 175-179, 2004 - C型肝硬変.血小板滅少例(血小板数58000～85000/μ 1)に対する少量INF-β療法の治療成績
山浦高裕，一條哲也，海野 洋，岡庭信司，中村喜行，太田裕志，松尾恭介，六波羅明紀，松本晶博，吉澤 要，田中栄司，清澤研道
飯田市立病院医誌, 10, 21-24, 2004 - Peroxisome proliferator-activated receptor a protects against alcohol-induced liver damage
Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, TanakaE, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T
Hepatology, 40(4), 972-980, 2004 - Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting abiochemical response
Imai Y, Kasahara A, Tanaka H, Okanoue T, Hiramatsu N, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Sasaki Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N
J Gastroenterol, 39(11), 1069-1077, 2004 - Inteferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death
Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N
J ViralHepat, 11(2), 148-156, 2004 - Hepatocellular carcinoma: recent trends in Japan
Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E
Gastroenteroiogy, 127(5), S17-S26, 2004 - Nagano Interferon Treatment Research Group: Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C:analysis by a prospective study
Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K
J Gastroenterol, 39(7), 674-680, 2004 - Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C
Tanaka .N, Ishida F, Tanaka E
N Engl J Med, 350(12), 1264-1265, 2004 - Hepatic hydrothorax in the absence of ascites diagnosed by intraperitoneal spraying of indocyanine green
Umino J, Tanaka E, Ichijoh T, Muraki T, Orii K, Yoshizawa K, Kiyosawa K
Intem Med, 43(4), 283-288, 2004 - Hepatitis B virus genotype G is an extremely rare genotype in Japan
Kato, H; Sugauchi, F; Ozasa, A; Kato, T; Tanaka, Y; Sakugawa, H; Sata, M; Hino, K; Onji, M; Okanoue, T; Tanaka, E; Kawata, S; Suzuki, K; Hige, S; Ohno, T; Orito, E; Ueda, R; Mizokami, M
HEPATOLOGY RESEARCH, 30(4), 199-203, 2004 - Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; A marker distinct from viral DNA for monitoring lamivudine treatment.
Rokuhara, A; Kimura, T; Matsumoto, A; Tanaka, E; Maki, N; Kiyosawa, K
Hepatology, 38(4), 726A-727A, Oct. 2003 - Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, Sun X, Yagi S, Maki N, Kiyosawa K
J Viral Hepat, 10(4), 324-330, Jul. 2003 - その他のウイルスによる肝炎
梅村武司，田中榮司
臨床医, 29, 645-647, 2003 - 成人生体肝移植・ウイルス肝炎術後再発 予防と治療
清澤研道，田中榮司
今日の移植, 16, 473-478, 2003 - C型肝炎診断の新展開
田中榮司
Medical Technology, 31, 138-144, 2003 - NASHの成因と病態 肝炎ウイルスとNASH
田中直樹，田中榮司，清澤研道
臨床消化器内科, 18, 1269-1274, 2003 - Crohn病の良性狭窄病変に対する内視鏡的バルーン拡張術の検討
村木 崇，赤松泰次，横澤秀一，三澤倫子，立岩伸之，進士明宏，小松健一，川村葉子，高山真理，浜野英明，越知泰英，中村 直，吉澤 要，田中榮司，清澤研道
ENDOSCOPIC FORUM for digestive disease, 19, 167-173, 2003 - B型慢性肝炎に対するラミブジン治療のウイルス学的効果予測式の作成
六波羅明紀，松本晶博，武藤英知，沖山 洋，田中直樹，丸山敦史，山浦高裕，折井幸司，一條哲也，吉澤 要，小林正和，袖山 健，田中榮司，清澤研道
肝臓, 44, 182-183, 2003 - Clinical significance of SEN virus infection in patients on maintenance haemodialysis
Kobayashi N, Tanaka E, Umemura T, Matsumoto A, Iijima T, Higuchi M, Hora K, Kiyosawa K
Nephrol Dial Transplant, 18(2), 348-352, 2003 - Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence
Gad A, Tanaka E, Matsumoto A, el-Hamid Serwah A, Ali K, Makledy F, el-Gohary A, Orii K, Ijima A, Rokuhara A, Yoshizawa K, Nooman Z, Kiyosawa K
J Med Virol, 70(4), 594-599, 2003 - New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA
Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Maki N
J Clin Microbiol, 41(5), 1901-1906, 2003 - Seroepidemiology of Helicobacter pylori and hepatitis A virus and the mode of transmission of infection: a 9-year cohort study in rural Japan
Malaty HM, Tanaka E, Kumagai T, Ota H, Kiyosawa K, Graham DY, Katsuyama T
Clin Infect Dis, 37(8), 1067-1072, 2003 - Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis
Umemura T, Tanaka E, Ostapowicz G, Brown KE, Heringlake S, Tassopoulos NC, Wang RY, Yeo AE, Shih JW, Orii K, Young NS, Hatzakis A, Manns MP, Lee WM, Kiyosawa K, Alter HJ
J Infect Dis, 188(10), 1545-1552, 2003 - A case-control study for early prediction ofhepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter
Yamaura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y, Kiyosawa K
J Med Virol, 70(4), 545-552, 2003 - Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease
Yoshizawa K, Ota M, Saito S, Maruyama A, Yamaura T, Rokuhara A, Orii K, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K
Tissue Antigens, 61(2), 159-165, 2003 - Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities
Fujiwara, K; Yokosuka, O; Imazeki, F; Saisho, H; Saotome, N; Suzuki, K; Okita, K; Tanaka, E; Omata, M
HEPATOLOGY RESEARCH, 25(2), 124-134, 2003 - Riskfactors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
Imamura, H; Matsuyama, Y; Tanaka, E; Ohkubo, T; Hasegawa, K; Miyagawa, S; Sugawara, Y; Minagawa, M; Takayama, T; Kawasaki, S; Makuuchi, M
JOURNAL OF HEPATOLOGY, 38(2), 200-207, 2003 - NASHと非A非B非C型肝炎ウイルス
田中直樹，田中榮司，清澤研道
肝・胆・膵, 44, 471-476, 2002 - HCV感染の診断と検査 HCVコア抗原定量とHCVセログループ その利用法
田中榮司
臨床医, 28, 47-49, 2002 - HCV関連マーカー測定法の進歩
田中榮司
臨床検査, 46, 243-250, 2002 - ウイルス性肝炎の現況 SENウイルスとその臨床的意義
田中榮司
医学のあゆみ, 200, 33-36, 2002 - 慢性肝炎診療マニュアルをめぐって 肝炎ウイルスの血液感染/母子感染/その他
田中榮司
綜合臨床, 51, 1929-1934, 2002 - 2度の帝王切開を契機に増悪したと考えられる巨大肝血管腫によるKasabach-Merritt症候群の1例
六波羅明紀，吉澤 要，山浦高裕，丸山敦史，折井幸司，一條哲也，田中榮司，角谷眞澄，清澤研道
肝臓, 43, 185-191, 2002 - Clinical significance of TT virus infection in maintenance hemodialysis patients of an endemic area for hepatitis C infection
Gad A, Tanaka E, Orii K, Rokuhara A, Nooman Z, El-Hamid Serwah A,El-Sherif A, El-Essawy M, Yoshizawa K, Kiyosawa K
Hepatol Res, 22(1), 13-19, 2002 - Epidemiology and clinical aspects on hepatitis C
Higuchi M, Tanaka E, Kiyosawa K
Jpn J Infect Dis, 55(3), 69-77, 2002 - Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N
J Clin Microbiol, 40(2), 439-445, 2002 - Characteristics of hepatocellular carcinoma in Japan
Kiyosawa K, Tanaka E
ONCOLOGY, 62, 5-7, 2002 - SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C
Umemura T, Alter HJ, Tanaka E, Orii K, Yeo AE, Shih JW, Matsumoto A, Yoshizawa K, Kiyosawa K
Hepatology, 35(4), 953-959, 2002 - Development of small hepatocellular carcinoma in a patient with chronic hepatitis C after 77 months of a sustained and complete response to interferon therapy
Yamaura T, Matsumoto A, Rokuhara A, Ichijo T, Tanaka E, Hanazaki K, Kajikawa S, Kiyosawa K
J Gastroenterol Hepatol, 17(11), 1229-1235, 2002 - Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines
Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K
Cancer, 95(10), 2243-2251, 2002 - The role of SEN virus infection in various liver diseases from different geographical regions.
Umemura, T; Tanaka, E; Lee, WM; Ostapowicz, G; Heringlake, S; Manns, MP; Tasopoulos, NC; Hatzakis, A; Brown, KE; Young, NS; Wang, R; Yeo, A; Shih, J; Orii, K; Kiyosawa, K; Alter, HJ
Hepatology, 36(4), 646A-646A, 2002 - Soluble asialoglycoprotein receptors reflect the apoptosis of hepatocytes
Kakegawa, T; Ise, H; Sugihara, N; Nikaido, T; Negishi, N; Akaike, T; Tanaka, E
CELL TRANSPLANTATION, 11(5), 407-415, 2002 - Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect
Gad, A; Tanaka, E; Orii, K; Rokuhara, A; Nooman, Z; Serwah, AH; Shoair, M; Yoshizawa, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 36(11), 753-758, 2001 - Association between SEN virus infection and hepatitis C in Japan
Umemura, T; Alter, HJ; Tanaka, E; Yeo, AET; Shih, JWK; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
JOURNAL OF INFECTIOUS DISEASES, 184(10), 1246-1251, 2001 - SEN virus infection in high- and non-endemic areas for hepatitis C in Japan.
Umemura, T; Alter, HJ; Tanaka, E; Yeo, AE; Shih, JW; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
Hepatology, 34(4), 487A-487A, 2001 - 8-year birth cohort study of the seroepidemiology of Helicobacter pylori infection and hepatitis A virus in rural Japan
Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, T; Kiyosawa, K; Graham, DY
Gut, 49, A32-A32, 2001 - Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
Orito, E; Ichida, T; Sakugawa, H; Sata, M; Horiike, N; Hino, K; Okita, K; Okanoue, T; Iino, S; Tanaka, E; Suzuki, K; Watanabe, H; Hige, S; Mizokami, M
Hepatology, 34(3), 590-594, 2001 - Development of a sensitive enzyme-immunoassay for hepatitis B virus core-related antigens.
Kimura, T; Rokuhara, A; Sakamoto, Y; Yagi, S; Tanaka, E; Kiyosawa, K; Maki, N
CLINICAL CHEMISTRY, 47(6), A94-A94, 2001 - A birth cohort study of the seroepidemiologic association of Helicobacter pylori infection and Hepatitis A virus in rural Japan
Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, ET; Kiyosawa, K; Graham, DY; Katsuyama, T
GASTROENTEROLOGY, 120(5), A128-A128, 2001 - Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
Hosaka, S; Kawa, S; Aoki, Y; Tanaka, E; Yoshizawa, K; Karasawa, Y; Hosaka, N
FOOD AND CHEMICAL TOXICOLOGY, 39(6), 557-561, 2001 - Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B
Kiyosawa, K; Tanaka, E
JOURNAL OF GASTROENTEROLOGY, 36(2), 139-141, 2001 - Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay
Tanaka E 他10名
J Gastroenterol, 36(5), 317-321, 2001 - De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: Analysis by determining complete sequence of the genome
Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K
JOURNAL OF MEDICAL VIROLOGY, 62(4), 471-478, Dec. 2000 - De novo infection of hepatitis B virus in patients with orthotopic liver transplantation analysis by determining the complete sequence of the genome.
Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K
Hepatology, 32(4), 597A-597A, Oct. 2000 - Natural history of acute hepatitis C
Tanaka E 他1
J Gastroenterol Hepatol, 15 (suppl), E97-E104, 2000 - Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt
Amal G, Tanaka E 他6名
J Med Virol, 60(2), 177-181, 2000 - Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus
Orii K, Tanaka E 他5名
INTERVIROLOGY, 43(3), 139-145, 2000 - Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA
Tanaka E 他6名
Hepatology, 32(2), 388-393, 2000 - Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon
Nishizawa, Y; Tanaka, E; Orii, K; Rokuhara, A; Ichijo, T; Yoshizawa, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 15(11), 1292-1297, 2000 - The prevalence of SEN virus infection in Japanese patients with viral hepatitis and liver disease.
Umemura, T; Yeo, AE; Shih, Y; Matsumoto, A; Orii, K; Tanaka, E; Kiyosawa, K; Primi, D
Hepatology, 32(4), 381A-381A, 2000 - The role of hepatitis C virus infection in glomerulopathy
Muramatsu, T; Hora, K; Ako, S; Tachibana, N; Hora, K; Tanaka, E
HEPATOLOGY RESEARCH, 18(3), 190-202, 2000 - A new era of interferon treatment for chronic hepatitis C is coming
Kiyosawa, K; Tanaka, E
JOURNAL OF GASTROENTEROLOGY, 35(8), 652-654, 2000 - T cell repertoire in the liver of patients with primary biliary cirrhosis
Inada, H; Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Tanaka, E; Kiyosawa, K
HUMAN IMMUNOLOGY, 61(7), 675-683, 2000 - Risk factors contributing to early and late phases of intrahepatic recurrence of hepatocellular carcinoma (HCC) after hepatectomy.
Imamura, H; Tanaka, E; Matsuyama, Y; Miyagawa, SI; Kawasaki, S; Kubota, K; Takayama, T; Makuuchi, M
GASTROENTEROLOGY, 118(4), A916-A916, 2000 - Analysis of T cell repertoire in the liver of patients with chronic hepatitis C
Umemura, T; Yoshizawa, K; Ota, M; Katsuyama, Y; Inada, H; Tanaka, E; Kiyosawa,K
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 121(1), 120-126, 2000 - Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection
Malaty, HM; Kumagai, T; Tanaka, E; Ota, H; Kiyosawa, K; Graham, DY; Katsuyama, T
JOURNAL OF CLINICAL MICROBIOLOGY, 38(5), 1971-1973, 2000 - Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum
Iijima, A; Tanaka, E; Kobayashi,M; Yagi, S; Mizokami, M; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 15(3), 311-319, 2000 - Does GBV-C/HGV replicate in the liver?
Tanaka, E
JOURNAL OF GASTROENTEROLOGY, 34(6), 721-723, 1999 - Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro
Rumin, S; Berthillon, P; Tanaka, E; Kiyosawa, K; Trabaud, MA; Bizollon, T; Gouillat, C; Gripon, P; Guguen-Guillouzo, C; Inchauspe, G; Trepo, C
JOURNAL OF GENERAL VIROLOGY, 80, 3007-3018, 1999 - T cell repertoire in the liver ofpatients with autoimmune hepatitis
Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Umemura, T; Tanaka, E; Kiyosawa, K
HUMAN IMMUNOLOGY, 60(9), 806-815, 1999 - GB virus C/hepatitis G virus
Kiyosawa, K; Tanaka, E
INTERVIROLOGY, 42(2-3), 185-195, 1999 - Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination
Vidalin, O; Tanaka, E; Spengler, U; Trepo, C; Inchauspe, G
DNA AND CELL BIOLOGY, 18(8), 611-621, 1999 - Transfusion-associated TT virus infection and its relationship to liver disease
Matsumoto, A; Yeo, AET; Shih, JWK; Tanaka, E; Kiyosawa, K; Alter, HJ
Hepatology, 30(1), 283-288, 1999 - Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen
Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S
JOURNAL OF CLINICAL MICROBIOLOGY, 37(6), 1802-1808, 1999 - Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis
Orii, K; Tanaka, E; Umemura, T; Rokuhara, A; Iijima, A; Yoshizawa, K; Imai, H; Kiyosawa, K
HEPATOLOGY RESEARCH, 14(2), 161-170, 1999 - Transmission of and liver injury by TT virus in patients on maintenance hemodialysis
Oguchi, T; Tanaka, E; Orii, K; Kobayashi, M; Hora, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 34(2), 234-240, 1999 - TT virus infection in an area of high-endemicity for hepatitisC
Umemura, T; Tanaka, E; Ota, M; Orii, K; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
HEPATOLOGY RESEARCH, 13(3), 212-220, 1999 - Detection of GB virus-C hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue
Kobayashi, M; Tanaka, E; Nakayama, J; Furuwatari, C; Katsuyama, T; Kawasaki, S; Kiyosawa, K
JOURNAL OFMEDICAL VIROLOGY, 57(2), 114-121, 1999 - Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic
Tanaka E 他8名
J Clin Microbiol, 36(1), 110-114, 1998 - Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: Report of a case
Kita, Y; Lake, JR; Ferrell, LD; Mori, M; Roberts, JP; Kakizoe, S; Kiyosawa, K; Tanaka, E; Shiga, J; Takikawa, H; Inoue, Y; Ohtake, T; Ohtomo, K; Yotsuyanagi, H; Oka, T; Harihara, Y; Takayama, T; Kubota, K; Kawarasaki, H; Hashikura, Y; Kawasaki, S; Ascher, NL; Makuuchi, M
TRANSPLANTATION PROCEEDINGS, 30(7), 3321-3323, 1998 - T cell receptor usage of liver infiltrating T cells in patients with autoimmune hepatitis.
Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Imai, H; Tanaka, E; Kiyosawa, K
Hepatology, 28(4), 191A-191A, 1998 - Clinical performance of quantitative and highly sensitive HCV core antigen assay system.
Tanaka, E; Aoyagi, K; Nishizawa, Y; Umemura, T; Orii, K; Rokuhara, A; Iijima, A; Imai, H; Yoshizawa, K; Yagi, S; Hasegawa, A; Kiyosawa, K
Hepatology, 28(4), 279A-279A, 1998 - Development of highly sensitive enzyme-immunoassay for hepatitis C virus core antigen.
Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S
Hepatology, 28(4), 568A-568A, 1998 - Acquistion vs. loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
Kumagai, T; Malaty, HM; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T
Gut, 43, A39-A39, 1998 - An 8-year birth cohort study shows adult-to-child transmission of H-pylori infection
Malaty, HM; Kumagai, T; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T
Gut, 43, A40-A40, 1998 - Acquisition versus loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
Kumagai, T; Malaty, HM; Graham, DY; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
JOURNAL OF INFECTIOUS DISEASES, 178(3), 717-721, 1998 - Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance haemodialysis: Comparison among haemodialysis units
Kobayashi, M; Tanaka, E; Oguchi, H; Hora, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 13(6), 604-609, 1998 - Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C
Kobayashi, M; Tanaka, E; Matsumoto, A; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 33(4), 508-511, 1998 - Two patients with acute hepatitis B with suspected sexual transmission of hepatitis G virus
Tanaka, E; Nakatsuji, Y; Kobayashi, M; Orii, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 33(3), 419-423, 1998 - Acquisition and loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study.
Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
GASTROENTEROLOGY, 114(4), A190-A190, 1998 - Adult-to-child transmission of Helicobacter pylori infection: Results from an 8-year birth cohort study.
Malaty, HM; Graham, DY; Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
GASTROENTEROLOGY, 114(4), A211-A211, 1998 - Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis
TANAKA Eiji 他7名
J Viral Hepatitis, 5(3), 153-159, 1998 - Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis
Ideura, T; Tanaka, E; Nakatsuji, Y; Kobayashi, M; Kanno, Y; Oguchi, H; Hora, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(11), 762-765, 1997 - Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery frominfection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors
Tacke, M; Schmolke, S; Schlueter, V; Sauleda, S; Esteban, JI; Tanaka, E; Kiyosawa, K; Alter, HJ; Schmitt, U; Hess, G; OfenlochHaehnle, B; Engel, AM
Hepatology, 26(6), 1626-1633, 1997 - Past and present infections ofhepatitis G virus in high-endemic area for hepatitis C; Comparison with nonendemic area.
Tanaka, E; Tacke, M; Kobayashi, M; Nakatsuji, Y; Kiyosawa, K; Schmolke, S; Engel, AM; Hess, G; Alter, HJ
Hepatology, 26(4), 797-797, 1997 - Long-term prognosis of type C chronic hepatitis patients treated with interferon; Development of hepatocellular carcinoma.
Iijima, A; Sodeyama, T; Inada, H; Ichijo, T; Kobayashi, M; Yamada, S; Imai, H; Yoshizawa, K; Tanaka, E; Kiyosawa, K
Hepatology, 26(4), 1599-1599, 1997 - Hepatitis G virus GB virus C infection in an area of high endemic hepatitis C virus infection
Tanaka, E; Nakatsuji, Y; Kobayashi, M; Iijima, A; Ichijo, T; Imai, H; Yoshizawa, K; Sodeyama, T; Kiyosawa, K
HEPATOLOGY RESEARCH, 7(2), 130-135, 1997 - Quantitative measurement of HCV RNA in the serum: A comparison of three assays based on different principles
Ichijo, T; Matsumoto, A; Kobayashi, M; Furihata, K; Tanaka, E
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(7), 500-506, 1997 - A prospective trial to change the administration dose of interferon according to a decrease in serum HCV-RNA in chronic hepatitis C.
Sodeyama, T; Matsumoto, A; Tanaka, E; Iizima, A; Yoshizawa, K; Imai, H; Kiyosawa, K
GASTROENTEROLOGY, 112(4), A1386-A1386, 1997 - Autoimmune hepatitis type 1 without evidence of hepatitis G virus infection
Ichijo, T; Nakatsuji, Y; Tanaka, E; Alter, HJ; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 6(5), 219-224, 1997 - Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C
Kobayashi, M; Tanaka, E; Matsumoto, A; Ichijo, T; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(1), 73-76, 1997 - Hepatitis G virus GB virus C infection in patients with chronic non-B, non-C hepatitis
Tanaka, E; Yamaguchi, K; Uemura, K; Kobayashi, M; Iijima, A; Kiyosawa, K; Yagi, S; Hasegawa, A
INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 6(3-4), 137-143, 1997 - Effect of hepatitis G virus infection on chronic hepatitis C
Tanaka E 他8名
Ann Intern Med, 125(9), 740-743, 1996 - Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa
Tanaka E 他7名
Hepatology, 23(6), 1330-1333, 1996 - The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses
Kobayashi M, Tanaka E 他4名
Hepatology, 23(4), 695-699, 1996 - Budd-Chiari syndrome caused by hepatic vein thrombosis in a patient with myeloproliferative disorder
Usui, T; Kitano, K; Midorikawa, T; Yoshizawa, K; Kobayashi, H; Tanaka, E; Matsunami, H; Kawasaki, S; Kiyosawa, K
INTERNAL MEDICINE, 35(11), 871-875, 1996 - Prevalence and disease association of hepatitis G virus infection in Japan
Nakatsuji, Y; Shih, JWK; Tanaka, E; Kiyosawa, K; Wages, J; Kim, JP; Alter, HJ
JOURNAL OF VIRAL HEPATITIS, 3(6), 307-316, 1996 - Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K
THROMBOSIS AND HAEMOSTASIS, 76(4), 545-548, 1996 - Effect of hepatitis G virus co-infection on patients with chronic hepatitis C
Tanaka, E; Alter, HJ; Nakatsuji, Y; Shih, JWK; Kim, JP; Matsumoto, A; Kobayashi, M; Kiyosawa, K
Hepatology, 24(4), 400-400, 1996 - Hepatitis G virus (HGV) infection in Japanese patients infected with hepatitis C virus (HCV).
Nakatsuji, Y; Shih, JWK; Kobayashi, M; Tanaka, E; Kiyosawa, K; Kim, JP; Alter, HJ
Hepatology, 24(4), 403-403, 1996 - Lymphocyte proliferative responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C
Mori, H; Yabu, K; Yoshizawa, K; Tanaka, E; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 11(8), 697-704, 1996 - Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)
Kashiwakuma, T; Hasegawa, A; Kajita, T; Takata, A; Mori, H; Ohta, Y; Tanaka,E;Kiyosawa, K; Tanaka, T; Tanaka, S; Hattori, N; Kohara, M
JOURNAL OF IMMUNOLOGICAL METHODS, 190(1), 79-89, 1996 - Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia
Tanaka, T; Lau, JYN; Mizokami, M; Orito, E; Tanaka, E; Kiyosawa, K; Yasui, K; Ohta, Y; Hasegawa, A; Tanaka, S; Kohara, M
JOURNAL OF HEPATOLOGY, 23(6), 742-745, 1995 - Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K
BLOOD, 86(10), 3621-3621, 1995 - EPIDEMIOLOGY OF GENOTYPES OF HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITHTYPE-C CHRONIC LIVER-DISEASES - A MULTI-INSTITUTION ANALYSIS
TANAKA, E; KIYOSAWA, K; MATSUSHIMA, T; ISHIKAWA, K; HINO, K; TANAKA, S; NOSE, H; KUMADA, H; IINO, S; KAMIMURA, T; UNOURA, M; MIZOKAMI, M; OKANOUE, T; KUROKI, T; YAMADA, G; MIURA, T; YANO, M; TSUBOUCHI, H; KOHARA, M; SATO, S; HATTORI, N; FURUTA, S; KARINO, Y; SAINOKAMI, S; TANAKA, T; OKADA, S; CHAYAMA, K; YASUDA, K; KUWANA, K; KANEKO, S; MIZOGUCHI, N; YASUI, K; TAKEDA, T; KISHI, F; YATSUHASHI, H; MARUYAMA, T; TSUKIYAMAKOHARA, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 10(5), 538-545, 1995 - ACUTE HEPATITIS-C TRANSMITTED BY NEEDLESTICK ACCIDENT DESPITE SHORT-DURATION INTERFERON TREATMENT
NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; MATSUMOTO, A; ICHIJO, T; MIZOKAMI, M; FURUTA, S
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 10(5), 609-611, 1995 - PREVALENCE OF HEPATITIS-G VIRUS (HGV) IN JAPAN
NAKATSUJI, Y; SHIH, JWK; TANAKA, E; WAGES, J; KIYOSAWA, K; KIM, JP; ALTER, HJ
Hepatology, 22(4), 303-303, 1995 - CLINICAL-APPLICATION OF A FLUORESCENCE ENZYME-IMMUNOASSAY FOR HCV CORE PROTEIN
TANAKA, E; MATSUMOTO, A; KOBAYASHI, M; ICHIJO, T; IMAI, H; SODEYAMA, T; KIYOSAWA, K; OHTA, Y; HASEGAWA, A; KOHARA, M
Hepatology, 22(4), 995-995, 1995 - SIMPLE FLUORESCENT EIA FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA
Tanaka, T; Lau, JYN; Mizokami, M; Orito, E; Tanaka, E; Kiyosawa, K; Yasui, K; Ohta, Y; Hasegawa, A; Tanaka, S; Kohara, M
Hepatology, 22(4), 996-996, 1995 - USEFULNESS OF SIMPLE ASSAYS FOR SERUM CONCENTRATION OF HEPATITIS-C VIRUS-RNA AND HCV GENOTYPE IN PREDICTING THE RESPONSE OF PATIENTS WITH CHRONIC HEPATITIS-C TO INTERFERON ALPHA-2A THERAPY
SUZUKI, T; TANAKA, E; MATSUMOTO, A; URUSHIHARA, A; SODEYAMA, T
JOURNAL OF MEDICAL VIROLOGY, 46(2), 162-168, 1995 - NATURAL-HISTORY OF HEPATITIS-C
KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
INTERVIROLOGY, 37(2), 101-107, 1994 - IMMUNOPEROXIDASE STAINING OF HEPATITIS-C VIRUS IN FORMALIN-FIXED, PARAFFIN-EMBEDDED NEEDLE LIVER BIOPSIES
UCHIDA, T; SHIKATA, T; TANAKA, E; KIYOSAWA, K
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 424(5), 465-469, 1994 - PREVALENCE OF HEPATITIS-C VIRUS WITH DIFFERENT GENOTYPES DETERMINED BY A GROUP-SPECIFIC ANTIBODY-ASSAY IN JAPANESE PATIENTS WITH CHRONIC LIVER-DISEASES DUE TO HEPATITIS-C VIRUS-INFECTION
TANAKA, E; KIYOSAWA, K; MATSUMOTO, A; SODEYAMA, T; URUSHIHARA, A; SUZUKI, T; KOBAYASHI, M; FURUTA, S
JAPANESE JOURNAL OF MEDICAL SCIENCE&BIOLOGY, 47(1), 47-57, 1994 - VIRAL AND HOST FACTORS THAT CONTRIBUTE TO EFFICACY OF INTERFERON-ALPHA(2A) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
MATSUMOTO, A; TANAKA, E; SUZUKI, T; OGATA, H; KIYOSAWA, K
DIGESTIVE DISEASES AND SCIENCES, 39(6), 1273-1280, 1994 - TRANSMISSION OF HEPATITIS-C IN AN ISOLATED AREA IN JAPAN - COMMUNITY-ACQUIRED INFECTION
KIYOSAWA, K; TANAKA, E; SODEYAMA, T; YOSHIZAWA, K; YABU, K; FURUTA, K; IMAI, H; NAKANO, Y; USUDA, S;UEMURA, K; FURUTA, S; WATANABE, Y; WATANABE, J; FUKUDA, Y; TAKAYAMA, T; URUSHIBARA, A; MATSUMOTO, A; MORI, H; KOBAYASHI, M; SUZUKI, T; YAMADA, S; SEKI, T; SHIMIZU, S; NAKAMURA, M; SONE, H; HARA, K; ICHIJO, T; OHIKE, Y; GIBO, Y; NAKATSUJI, Y; YODA, H; TSUCHIYA, K; HAYATA, T; IMAI, Y; KOBAYASHI, M; HARA, N
GASTROENTEROLOGY, 106(6), 1596-1602, 1994 - SERUM COLLAGEN TYPE-IVFOR THE ASSESSMENT OF FIBROSIS AND RESISTANCE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C
YABU, K; KIYOSAWA, K; MORI, H; MATSUMOTO, A; YOSHIZAWA, K; TANAKA, E; FURUTA, S
Scandinavian journal of gastroenterology, 29(5), 474-479, 1994 - ADAPTATION OF HEPATITIS-C VIRUS FOR PERSISTENT INFECTION IN PATIENTS WITH ACUTE HEPATITIS
YAMAGUCHI, K; TANAKA, E; HIGASHI, K; KIYOSAWA, K; MATSUMOTO, A; FURUTA, S; HASEGAWA, A; TANAKA, S; KOHARA, M
GASTROENTEROLOGY, 106(5), 1344-1348, 1994 - SILENT HEPATITIS-B VIRUS MUTANTS ARE RESPONSIBLE FOR NON-A, NON-B, NON-C, NON-D, NON-E HEPATITIS
UCHIDA, T; SHIMOJIMA, M; GOTOH, K; SHIKATA, T; TANAKA, E; KIYOSAWA, K
MICROBIOLOGY AND IMMUNOLOGY, 38(4), 281-285, 1994 - CHANGES IN ANTIBODY-TITERS TO HEPATITIS-C VIRUS FOLLOWING INTERFERON THERAPY FOR CHRONIC INFECTION
URUSHIHARA, A; SODEYAMA, T; MATSUMOTO, A; TANAKA, E
JOURNAL OF MEDICAL VIROLOGY, 42(4), 348-356, 1994 - TYPE C CHRONIC HEPATITIS ASSOCIATED WITH THROMBOCYTOPENIA IN 2 PATIENTS
YABU, K; KIYOSAWA, K; AKO, S; USUDA, S; YOSHIZAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 9(1), 99-104, 1994 - QUANTITATIVE ASSAY FOR ANTI-HCV-CORE ANTIBODY IN HEALTHY-INDIVIDUALS FOUND ANTI-HCV POSITIVE DURING A MASS-SCREENING
URUSHIHARA, A; SUZUKI, T; MATSUMOTO, A; TANAKA, E; SODEYAMA, T; KIYOSAWA, K; FURUTA, S
INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 2(1), 47-51, 1994 - HUMAN-LEUKOCYTE ANTIGEN CLASS-II MOLECULES AND PRIMARY BILIARY-CIRRHOSIS SUSCEPTIBILITY IN JAPANESE PATIENTS
SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; MIZUKI, N; ANDO, A; INOKO, H
Hepatology, 18(4), A218-A218, 1993 - IMMUNE-RESPONSES TO HCV ANTIGENS OF THE PATIENTS WITH DIFFERENT HISTOLOGICAL STAGES IN CHRONIC HEPATITIS-C
MORI, H; YABU, K; YOSHIZAWA, K; USUDA, S; TANAKA, E; KIYOSAWA, K; HASEGAWA, A; KOHARA, M; FURUTA, S
Hepatology, 18(4), A245-A245, 1993 - FACTORS THAT CONTRIBUTE TO THE EFFICACY OF IFN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
TANAKA, E; MATSUMOTO, A; SUZUKI, T; URUSHIHARA, A; YOSHIZAWA, K; SODEYAMA, T; KIYOSAWA, K; FURUTA, S
Hepatology, 18(4), A258-A258, 1993 - LOW-PREVALENCE OF HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE-1
TANAKA, E; KIYOSAWA, K; SEKI, T; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; KUMAGAI, T; KOHARA, M
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 8(5), 442-447, 1993 - PROGNOSIS OF ASYMPTOMATIC HEPATITIS-B SURFACE-ANTIGEN CARRIERS
KIYOSAWA, K; SODEYAMA, T; TANAKA, E
ANNALS OF INTERNAL MEDICINE, 119(6), 535-535, 1993 - DETECTION OF HEPATITIS-C VIRUS MARKERS AND HEPATITIS-C VIRUS GENOMIC RNA AFTER NEEDLESTICK ACCIDENTS
SODEYAMA, T; KIYOSAWA, K; URUSHIHARA, A; MATSUMOTO, A; TANAKA, E; FURUTA, S; AKAHANE, Y
ARCHIVES OF INTERNAL MEDICINE, 153(13), 1565-1572, 1993 - ASSOCIATION OF PRIMARY BILIARY-CIRRHOSIS WITH HUMAN-LEUKOCYTE ANTIGEN-DPB1-ASTERISK-0501 IN JAPANESE PATIENTS
SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; KUMAGAI, T; MIZUKI, N; ANDO, A; INOKO, H
Hepatology, 18(1), 73-78, 1993 - PROLIFERATIVE ACTIVITY OF HEPATOCYTES IN CHRONIC VIRAL-HEPATITIS AS REVEALED BY IMMUNOHISTOCHEMISTRY FOR PROLIFERATING CELL NUCLEAR ANTIGEN
NAKAMURA, T; HAYAMA, M; SAKAI, T; HOTCHI, M; TANAKA, E
HUMAN PATHOLOGY, 24(7), 750-753, 1993 - COMPARISON OF SEROEPIDEMIOLOGY OF HEPATITIS-C IN BLOOD-DONORS BETWEEN BANGLADESH AND JAPAN
KHAN, M; HUSAIN, M; YANO, M; HASHIZUME, K; YOUSUF, M; TANAKA, E; MATSUMOTO, A; FURUTA, S; KIYOSAWA, K
GASTROENTEROLOGIA JAPONICA, 28, 28-31, 1993 - ANTI-C100 ANTIBODIES TO HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION TREATED WITH INTERFERON
NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; YOSHIZAWA, K; FURUTA, K; NAKATSUJI, Y; URUSHIHARA, A; FURUTA, S
Scandinavian journal of gastroenterology, 28(4), 335-342, 1993 - COMPARISON OF THE CLINICAL AND IMMUNOGENETIC FEATURES BETWEEN PATIENTS WITH AUTOIMMUNE HEPATITIS AND PATIENTS WITH TYPE-C CHRONICACTIVE HEPATITIS
KIYOSAWA, K; SEKI, T; TANAKA, E; SODEYAMA, T; FURUTA, K; FURUTA, S; HINO, K; OTA, M; INOKO, H
GASTROENTEROLOGIA JAPONICA, 28, 63-68, 1993 - CLINICAL-SIGNIFICANCE OF ANTIBODIES TO NONSTRUCTURAL AND CORE PROTEINS OF HEPATITIS-C VIRUS IN POSTTRANSFUSION HEPATITIS PATIENTS DURING LONG-TERM FOLLOW-UP
TANAKA, E; KIYOSAWA, K; NAKATSUJI, Y; INOUE, Y; MIYAMURA, T; CHIBA, J; FURUTA, S
JOURNAL OF MEDICAL VIROLOGY, 39(4), 318-324, 1993 - CAROLIS-DISEASE IN 3 SIBLINGS
YOSHIZAWA, K; KIYOSAWA, K; YABU, K; USUDA, S; SHIMIZU,S; FUJIMORI, Y; MUKAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
GASTROENTEROLOGIA JAPONICA, 27(6), 780-784, 1992 - PERFORMANCE OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY SYSTEM FOR ANTIBODIES TO HEPATITIS-C VIRUS WITH 2 NEW ANTIGENS (C11/C7)
SAITO, M; HASEGAWA, A; KASHIWAKUMA, T; KOHARA, M; SUGI, M; MIKI, K; YAMAMOTO, T; MORI, H; OHTA, Y; TANAKA, E; KIYOSAWA, K; FURUTA, S; WAKASHIMA, M; TANAKA, S; HATTORI, N
CLINICAL CHEMISTRY, 38(12), 2434-2439, 1992 - IMMUNOSUPPRESSIVE THERAPY PROMOTES THE REPLICATION OF HEPATITIS-C VIRUS, FOLLOWED BY EXACERBATION OF LIVER-DISEASE AFTER DOSAGE REDUCTION OR WITHDRAWAL
NAKATSUJI, Y; KIYOSAWA, K; FURIHATA, K; TANAKA, E; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; MAKUUCHI, M
Hepatology, 16(4), A215-A215, 1992 - PERSISTENCE OF VIREMIA IN PATIENTS WITH TYPE-C CHRONIC HEPATITIS DURING LONG-TERM FOLLOW-UP
YOUSUF, M; NAKANO, Y; TANAKA, E; SODEYAMA, T; KIYOSAWA, K
Scandinavian journal of gastroenterology, 27(9), 812-816, 1992 - NEW HEPATOCELLULAR-CARCINOMA CELL-LINE SUHC-1 ESTABLISHED FROM A PATIENT WITH HEPATITIS-C VIRUS-RNA IN SERUM
YOSHIZAWA, K; KIYOSAWA, K; USUDA, S; YABU, K; NAKATSUJI, Y; YAMADA, S; FURUTA, K; TANAKA, E; SODEYAMA, T; FURUTA, S; KANEKO, S; NAKANE, PK
JAPANESE JOURNAL OF CANCER RESEARCH, 83(8), 871-877, 1992 - DETECTION OF CHRONIC HEPATITIS-C VIRUS-INFECTION BY 4 DIAGNOSTIC SYSTEMS - 1ST-GENERATION AND 2ND-GENERATION ENZYME-LINKED-IMMUNOSORBENT-ASSAY, 2ND-GENERATION RECOMBINANT IMMUNOBLOT ASSAY AND NESTED POLYMERASE CHAIN-REACTION ANALYSIS
NAKATSUJI, Y; MATSUMOTO, A; TANAKA, E; OGATA, H; KIYOSAWA, K
Hepatology, 16(2), 300-305, 1992 - HEPATITIS-VIRUS INFECTION (HBV AND HCV) IN 11 JAPANESE HEMODIALYSIS UNITS
OGUCHI, H; MIYASAKA, M; TOKUNAGA, S;HORA, K; ICHIKAWA, S; OCHI, T; YAMADA, K; NAGASAWA, M; KANNO, Y; AIZAWA, T; WATANABE, H; YOSHIZAWA, S; SATO, K; TERASHIMA, M; YOSHIE, T; OGUCHI, S; TANAKA, E; KIYOSAWA, K; FURUTA, S
CLINICAL NEPHROLOGY, 38(1), 36-43, 1992 - PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE SCHOOLCHILDREN - COMPARISON WITH ADULT-BLOODDONORS
TANAKA, E; KIYOSAWA, K; SODEYAMA, T; HAYATA, T; OHIKE, Y; NAKANO, Y; YOSHIZAWA, K; FURUTA, S; WATANABE, Y; WATANABE, I; NISHIOKA, K
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 46(4), 460-464, 1992 - HIGH PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN HEAVY DRINKERS WITH CHRONIC LIVER-DISEASES IN JAPAN
SHIMIZU, S; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, M
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 7(1), 30-35, 1992 - HEPATITIS-C IN HOSPITAL EMPLOYEES WITH NEEDLESTICK INJURIES
KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, Y; FURUTA, S; NISHIOKA, K; PURCELL, RH; ALTER, HJ
ANNALS OF INTERNAL MEDICINE, 115(5), 367-369, 1991 - EXPRESSION OF HEPATITIS-B SURFACE-ANTIGEN SUBTYPES IN LIVER OF PATIENTS WITH HEPATOCELLULAR-CARCINOMA - COMPARISON OF SUBTYPES IN SERUM AND LIVER
NAKATSUJI, Y; KIYOSAWA, K; TANAKA, E; SODEYAMA, T; HORIGOME, N; KAJIKAWA,S; NAITO, S; AKAHANE, Y
LIVER, 11(3), 176-184, 1991 - INTRAFAMILIAL TRANSMISSION OF HEPATITIS-C VIRUS IN JAPAN
KIYOSAWA, K; SODEYAMA, T; TANAKA, E; SHIMIZU, S; FURUTA, S; MIYAZAKI, Y; AKAHANE, Y; SUZUKI, H
JOURNAL OF MEDICAL VIROLOGY, 33(2), 114-116, 1991 - SIGNIFICANCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITH VIRAL-HEPATITIS - RELATIONSHIP BETWEEN ANTI-HCV ANTIBODY AND THE PROGNOSIS OF NON-A, NON-B POSTTRANSFUSION HEPATITIS
TANAKA, E; KIYOSAWA, K; SODEYAMA, T; NAKANO, Y; YOSHIZAWA, K; HAYATA, T; SHIMIZU, S; NAKATSUJI, Y; KOIKE, Y; FURUTA, S
JOURNAL OF MEDICAL VIROLOGY, 33(2), 117-122, 1991 - A HIGH PREVALENCE OF ANTIBODY TO THE HEPATITIS-C VIRUS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA IN JAPAN
NISHIOKA, K; WATANABE, J; FURUTA, S; TANAKA, E; IINO, S; SUZUKI, H; TSUJI, T; YANO, M; KUO, G; CHOO, QL; HOUGHTON, M; ODA, T
Cancer, 67(2), 429-433, 1991 - TRANSITION OF ANTIBODY TO HEPATITIS-C VIRUS FROM CHRONIC HEPATITIS TO HEPATOCELLULAR-CARCINOMA
KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, K; USUDA, S; YOUSUF, M; FURUTA, S
JAPANESE JOURNAL OF CANCER RESEARCH, 81(11), 1089-1091, 1990 - INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS
KIYOSAWA, K; SODEYAMA, T; TANAKA, E; GIBO, Y; YOSHIZAWA, K; NAKANO, Y; FURUTA, S; AKAHANE, Y; NISHIOKA, K; PURCELL, RH; ALTER, HJ
Hepatology, 12(4), 671-675, 1990 - PREVALENCE OF ANTI-HCV ANTIBODY IN BLOOD-DONORS IN THE TOKYO AREA
WATANABE, J; MINEGISHI, K; MITSUMORI, T; ISHIFUJI, M; OGUCHI, T; UEDA, M; TOKUNAGA, E; TANAKA, E; KIYOSAWA, K; FURUTA, S; KATAYAMA, T; KUO, G; CHOO, QL; HOUGHTON, M; NISHIOKA, K
VOX SANGUINIS, 59(2), 86-88, 1990 - COMPARATIVE-STUDY OF CLINICAL, HISTOLOGICAL, AND IMMUNOLOGICAL RESPONSES TO INTERFERON THERAPY IN TYPE-NON-A, TYPE-NON-B, AND TYPE-B CHRONIC HEPATITIS
NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E
AMERICAN JOURNAL OF GASTROENTEROLOGY, 85(1), 24-29, 1990
Books and other publications
- C型肝炎のおはなし
田中榮司
シスメックス株式会社, 1-14 2019B型肝炎のおはなし
田中榮司
シスメックス株式会社, 1-14 2019日本肝臓学会（監修）, 西口修平（監修）, 上野義之, 日浅陽一, 榎本平之(編):肝硬変の成因別実態
杉浦亜弓, 城下智, 髙橋芳之, 栗林直矢, 山崎智生, 藤森尚之, 梅村武司, 松本晶博, 田中榮司, 長野県における肝硬変の成因実態
医学図書出版, 東京, 80-81 2019金井正光編：臨床検査法提要第32版
田中栄司, Contributor, Ⅲ肝・胆道機能検査
金原出版，東京, pp 1335-1387 2005林紀夫編：ウィルス性肝炎 消化器3
田中栄司, 急性肝炎の診断と治療（各論）（5）その他のウィルス性急性肝炎
最新医学社，大阪, pp 106-114 2005犬山シンポジウム記録刊行会編：ウイルス肝炎からの発癌とその予防
清澤研道，松本晶博，田中榮司，犬山肝炎研究グループ, B型慢性肝炎に対するラミブジン治療調査報告
アークメディア，東京, pp 159-165 2005林紀夫編：ウィルス性肝炎 消化器3
松本晶博，田中榮司，清澤研道, Contributor, B型慢性肝炎の予後（治療による発癌抑止)
最新医学社，大阪, pp 171-176 2005高久史麿，猿田亨男，北村惣一郎，福井次矢編：家庭医学大全科
田中栄司, 肝臓の病気/肝炎 C型急性肝炎 C型慢性肝炎 B型漫性肝炎
法研，東京, pp 2023-2029 2004二ノ宮節夫，冨士川恭輔，越知隆弘，国分正一，岩谷力編：今日の整形外科治療指針第5版
田中栄司, 術後肝障害の対策
医学書院，東京, pp 32-32 2004各務伸一編：コンセンサス2004肝疾患治療
田中栄司, C型肝炎治療の総論
アークメディア，東京, pp 77-83 2004林 紀夫，岡上 武，熊田博光編：C型慢性肝炎治療の新たなストラテジー(インターフェロン治療の今後)
田中栄司, C型慢性肝炎の治療とウイルスマーカー
先端医学社，東京, pp 51-57 2004清澤研道編：ナースのための肝炎看護ハンドブック C型肝炎対策を中心に
田中栄司, Contributor, C型肝炎の検査法
医薬ジャーナル社，東京, pp 33-41 2004清澤研道編：ナースのための肝炎看護ハンドブック C型肝炎対策を中心に
田中栄司, Contributor, C型肝炎の治療
医薬ジャーナル社，東京, pp 42-53 2004犬山シンポジウム記録刊行会編：B型・C型肝炎の病態と治療（第24回犬山シンポジウム）
清澤研道，田中榮司，松本晶博，熊田博光，小俣正男, Lamivudine 治療はB型肝炎の自然経過を修飾するか
アークメディア，東京, pp 3-9 2003熊田博光編：医学のあゆみ
田中榮司, ウイルス性肝炎の現況 SENウイルスとその臨床的意義
医歯薬出版，東京, pp 31-34 2003山口惠三，岩本愛吉編：日本臨床
田中榮司, グローバル時代の感染症学 ウイルス感染症 ウイルス性肝炎 E型肝炎
日本臨床社，東京, pp 249-253 2003石橋大海編：今月の治療
田中榮司, 慢性肝炎の治療と肝炎ウイルスマーカー
総合医学社，東京, pp 1105-1108 2003Hepatitis C virus in the etiology of hepatocellular carcinoma. Tabor E: Virus and Liver Cancer
Kiyosawa K, Tanaka E
Elsevier, pp 31-42 2002Hepatocellular carcinoma and Hepatitis C. Sarin SK. Okuda K: Hepatitis B and C carrier to cancer
Kiyosawa K, Tanaka E
ELSEVIER INDIA, pp 315-329 2002Ｃ型肝炎，自然経過と予後．矢野右人，林紀夫，沖田極編：コンセンサス肝疾患2002診断・治療と病態
田中榮司
日本メディカルセンター, pp 114-123 2002